Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Go behind the scenes of naming a drug

Suzanne Koven, MD
Meds
July 30, 2012
Share
Tweet
Share

One summer in college, when I couldn’t think of what else to do, I lived near campus in a punishingly hot walk up apartment, held down three boring jobs, and took intensive Latin. Every morning we met in a blissfully air-conditioned classroom–that was the upside!– to conjugate and decline: a whole year of Latin in 6 weeks. I remember nothing I learned, of course. I’m reminded of the great Woody Allen line: “I took a speed-reading course and read War and Peace in twenty minutes. It involves Russia.”

I do remember one thing I learned, though, which is that manufacturers often turn to the classics when naming products–including medications.

My Latin teacher was a young instructor who mentioned that he was supplementing his meager academic income by moonlighting with a marketing firm. His job was to use his knowledge of Latin and Greek to think up names for medications and other goods. “We want something like ‘Xerox’!” he told us the marketing firm told him. “Like ‘Xerox’!” (Xero is the Greek root meaning “dry”–xerostomia is the medical term for dry mouth–and so “Xerox” emphasized that this particular photocopy method didn’t involve wet ink–as anyone old enough to remember those sticky purple mimeographed sheets they used to hand out in school will appreciate…)

But I digress.

Every drug has at least three names. First, there’s the chemical name, then there’s the generic name, and then there is a brand name (sometimes more than one, if it’s produced by more than one company). For example, a commonly used diuretic’s chemical name is 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid, its generic name is furosemide and its brand name is Lasix.

Brand names and, to a lesser extent, generic names, are chosen with great care and often at great expense. Often, as I mentioned, Latin (or, less frequently, Greek) roots are chosen to enforce, even if only subliminally, our association with the drug. Some examples:

Paxil: an antidepressant and anti-anxiety drug (Pax=peace in Latin)

Lunesta: a sleeping medication (Luna=moon in Latin)

Viagra: a medication for erectile dysfunction (Vi[r]= man in Latin and Agra=field, usually farmed or fertile in Latin and Greek)

Fosamax: a drug for osteoporosis, or bone thinning (Os=bone Max=great in Latin)

Sometimes, drug names are chosen because of the meaning their sounds imply.

For example, several drugs that regulate heart rhythm end in the suffix -olol (propranolol, atenolol, nadolol)–those two echoed syllables mimicking the beating heart.

The letters “X,” “Z,” “N,” “Q,” and “K” connote cutting edge science, which the makers of Zantac, Nexium, and Protonix (all medicines for acid reflux) wish to convey.

“S.” “M,” “V,” “L” and “R” are “soft” letters, which the names of drugs for women are likely to include. Examples are Sarafem (for pre-menstrual syndrome) and Provera and Vivelle (hormone replacements). Many birth control pills employ these letters and sort of sound like women’s first names: Junel, Alesse, Apri, Mircette, Yasmin, etc.

ADVERTISEMENT

Medications marketed to men are more likely to contain a “hard” sound like “T,” “G,” “K” or “X”–like Flomax for enlarged prostate or Levitra, for erectile dysfunction. An exception is Cialis, also for ED and with only soft syllables but with a meaningful classical root (cael=sky in Latin, also connoting “up” or “above,” as in “ceiling.”)

Even when drugs have randomly chosen names, the companies that make them seek assistance. There’s actually a website with a program, Drug-o-Matic , that generates names for pharmaceuticals.

But the frequent use of certain classical roots (“Pro,” “Uni,” “Vi,” etc.) and of certain high tech sounding letters (“X” and “Z,” especially) has led to the problem of drugs that sound alike and can be easily confused. Up to 15% of errors in drug administration are estimated to be caused by the similarity of drug names such as Celebrex (for arthritis) and Celexa (for depression) or Zocor (for high cholesterol) and Zoloft (for depression or anxiety) or Lamisil (an anti fungal) and Lamictal (an anticonvulsant and mood stabilizer). Many hospitals have initiated systems to flag such drugs. At MGH the system is called SALAD (“sound alike/look alike drugs).

Here’s an interesting article from MIT with more information about the linguistics of drug naming.

So, it turns out that some of the effects drugs have on us occur even before we open the bottle–or so pharmaceutical companies would have it.

Suzanne Koven is an internal medicine physician who blogs at In Practice at Boston.com, where this article originally appeared. She is the author of Say Hello To A Better Body: Weight Loss and Fitness For Women Over 50. 

Prev

A tragedy based on administrative decisions

July 30, 2012 Kevin 14
…
Next

Go ahead and let teens read x-rays

July 30, 2012 Kevin 16
…

Tagged as: Medications, Primary Care

Post navigation

< Previous Post
A tragedy based on administrative decisions
Next Post >
Go ahead and let teens read x-rays

ADVERTISEMENT

More by Suzanne Koven, MD

  • A hospital leader speaks out against the transgender military ban

    Suzanne Koven, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Don’t hesitate to talk to your doctor about work

    Suzanne Koven, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Patients should silence their phones in the exam room

    Suzanne Koven, MD

More in Meds

  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Aging in place: Why home care must replace nursing homes

      Gene Uzawa Dorio, MD | Physician
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • When the clinic becomes the battlefield: Defending rural health care in the age of AI-driven attacks

      Holland Haynie, MD | Physician
    • How motherhood made me a better scientist [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • How motherhood made me a better scientist [PODCAST]

      The Podcast by KevinMD | Podcast
    • Public health under fire: Vaccine battle hits federal court

      J. Leonard Lichtenfeld, MD | Physician
    • How mindful leadership transforms physician wellness

      Jessie Mahoney, MD | Physician
    • How the quietly efficient physician can turn perception into power

      Olumuyiwa Bamgbade, MD | Physician
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why our fear of AI is really a fear of ourselves [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Aging in place: Why home care must replace nursing homes

      Gene Uzawa Dorio, MD | Physician
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • When the clinic becomes the battlefield: Defending rural health care in the age of AI-driven attacks

      Holland Haynie, MD | Physician
    • How motherhood made me a better scientist [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • How motherhood made me a better scientist [PODCAST]

      The Podcast by KevinMD | Podcast
    • Public health under fire: Vaccine battle hits federal court

      J. Leonard Lichtenfeld, MD | Physician
    • How mindful leadership transforms physician wellness

      Jessie Mahoney, MD | Physician
    • How the quietly efficient physician can turn perception into power

      Olumuyiwa Bamgbade, MD | Physician
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why our fear of AI is really a fear of ourselves [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Go behind the scenes of naming a drug
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...